copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
VCU researchers are developing a long-acting medication for . . . In hope of providing more treatment options for opioid use disorder, the VCU research team reworked nor-levo-alpha-acetylmethadol, a metabolite of a previous FDA-approved opiate dependence medication, into a new formulation that could be used to help patients with opioid addiction
Medical Breakthrough Offers Hope To Those Fighting Addiction A new drug that helps people with a substance dependency detoxification —in five days—from opioids and alcohol without painful withdrawal symptoms recently completed a proof-of-concept
Journavx: A Newly-Approved, Non-Opioid Pain Medication A newly approved, non-opioid pain medication By: Kailyn Tomilin, MPH Background The search for a solution to treat pain has led to the development of several pain medications over the years, some with dangerous effects An example of this is OxyContin, a dangerous, potent opioid pain medication that largely contributed to the opioid epidemic
New compound could supercharge naloxone in fight against . . . Addiction July 03, 2024 New compound could supercharge naloxone in fight against opioid overdoses By Nina Bai In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone's ability to fend off more potent opioids, with promising results in mice
Ozempic (and similar medications) may be the new treatment . . . Peer reviewed: Yes Method of research: Observational study Subject of study: People Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic weight-related conditions appear
Naltrexone Implant a Powerful New Tool in the Fight Against . . . Phase 2 of a clinical trial studying the efficacy of the long-term naltrexone implant to curb opioid addiction and overdose will soon open for enrollment at Columbia We spoke with Dr Christine Rohde about the impact of this important new treatment